Log in

Lexicon Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:LXRX)

$4.04
-0.20 (-4.72 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$3.99
Now: $4.04
$4.30
50-Day Range
$3.11
MA: $4.26
$5.23
52-Week Range
$1.13
Now: $4.04
$8.39
Volume911,492 shs
Average Volume875,233 shs
Market Capitalization$429.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.02

Earnings

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earnings Information

Lexicon Pharmaceuticals last released its quarterly earnings results on November 7th, 2019. The biopharmaceutical company reported $2.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.31 by $0.80. The business had revenue of $294.45 million for the quarter, compared to analysts' expectations of $12 million. Its revenue for the quarter was up 4124.5% compared to the same quarter last year. Lexicon Pharmaceuticals has generated ($1.14) earnings per share over the last year. Lexicon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 11th, 2020 based off prior year's report dates.

Lexicon Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earnings Estimates

2020 EPS Consensus Estimate: ($1.95)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.68)($0.68)($0.68)
Q2 20201($0.46)($0.46)($0.46)
Q3 20201($0.43)($0.43)($0.43)
Q4 20201($0.38)($0.38)($0.38)

5G Flaw Exposed: $5 Stock Holds Key To $12 Trillion Opportunity (Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Lexicon Pharmaceuticals (NASDAQ LXRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/11/2020
(Estimated)
       
11/7/2019Q3$1.31$2.11$1.95$12.00 million$294.45 millionTranscript
7/31/2019Q2($0.09)($0.22)($0.22)$28.52 million$9.68 millionListen
5/1/20193/31/2019($0.21)($0.21)($0.21)$13.26 million$9.20 millionN/A
3/13/201912/31/2018($0.28)($0.16)($0.16)$13.33 million$17.10 millionN/A
11/1/20189/30/2018($0.33)($0.26)($0.26)$12.56 million$6.90 millionListen
7/30/2018Q2 2018($0.35)($0.3280)($0.33)$15.88 million$13.75 millionN/A
5/3/2018Q1 2018($0.42)($0.40)($0.40)$25.30 million$25.21 millionN/A
2/22/2018Q4 2017($0.43)($0.31)($0.35)$29.84 million$33.05 millionN/A
11/8/2017Q3 2017($0.36)($0.2910)($0.29)$27.97 million$26.94 millionN/A
8/1/2017Q2 2017($0.45)($0.33)($0.33)$18.34 million$12.00 millionListen
5/2/2017Q1 2017($0.44)($0.33)($0.33)$14.81 million$18.29 millionN/A
3/3/2017Q4 2016($0.51)($0.31)($0.31)$15.56 million$23.00 millionN/A
11/1/2016Q316($0.50)($0.35)($0.35)$9.68 million$27.70 millionN/A
8/4/2016Q216($0.40)($0.37)($0.37)$12.36 million$20.10 millionN/A
5/3/2016Q1($0.30)($0.34)($0.34)$11.11 million$12.50 millionN/A
3/1/2016Q415($0.38)$0.76$0.76$21.50 million$127.30 millionN/A
11/6/2015Q3($0.36)($0.34)($0.34)$0.44 million$0.57 millionN/A
8/7/2015Q215($0.32)($0.27)($0.27)$0.45 million$376.00 millionN/A
4/29/2015Q115($0.04)($0.04)($0.28)$1.10 million$1.78 millionN/A
11/4/2014Q3($0.05)($0.05)($0.14)$0.16 million$0.40 millionN/A
8/7/2014Q214($0.05)($0.05)($0.35)$0.13 million$0.68 millionN/A
5/8/2014Q114($0.05)($0.06)($0.42)$0.12 million$277.00 millionN/A
2/28/2014Q4 2013($0.42)($0.21)($0.21)$1.66 million$1.40 millionN/A
11/12/2013Q3 2013($0.42)($0.42)($0.42)$1.59 million$0.24 millionListen
7/30/2013Q2 2013($0.35)($0.42)($0.42)$0.28 million$0.21 millionN/A
5/10/2013Q1 2013($0.35)($0.35)($0.35)$0.32 million$0.36 millionN/A
2/21/2013Q4 2012($0.05)($0.05)$0.37 million$0.22 millionN/A
11/6/2012Q312($0.06)($0.06)N/A
7/31/2012Q2 2012($0.42)($0.38)($0.38)N/A
5/3/2012Q1 2012($0.49)($0.39)($0.36)N/A
2/22/2012Q4 2011($0.56)($0.64)($0.60)N/A
11/1/2011Q3 2011($0.63)($0.54)($0.54)N/A
8/8/2011Q2 2011($0.63)($0.52)($0.48)N/A
5/3/2011Q1 2011($0.49)($0.59)($0.56)N/A
2/24/2011Q4 2010($0.56)($0.48)($0.48)N/A
11/5/2010Q3 2010($0.56)($0.57)($0.57)N/A
8/9/2010Q2 2010($0.49)($0.52)($0.52)N/A
5/10/2010Q1 2010($0.49)($0.92)($0.92)N/A
2/23/2010Q4 2009($0.98)($0.91)($0.91)N/A
10/27/2009Q3 2009($0.98)($0.97)($0.97)N/A
7/28/2009Q2 2009($1.12)($1.02)($1.02)N/A
4/28/2009Q1 2009($0.91)($1.13)($1.16)N/A
2/25/2009Q4 2008($1.19)($0.79)($0.79)N/A
10/30/2008Q3 2008($1.12)($1.03)($0.86)N/A
7/29/2008Q2 2008($1.12)($1.02)($1.02)N/A
4/29/2008Q1 2008($0.84)($0.92)($0.92)N/A
3/6/2008Q4 2007($0.91)($0.62)($0.62)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: Do You Need a Fiduciary?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel